Spironolactone And Hydrochlorothiazide Tablet
Product Images NDC 63629-1069

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Spironolactone And Hydrochlorothiazide (NDC 63629-1069). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl636291069

Spironolactone and Hydrochlorothiazide Tablets, USP 25 mg/25 mg oral tablets label by Bryant Ranch Prepack. The label shows drug name, strength, NDC 63629-1069, and packaging of 500 tablets. Includes manufacturer and storage instructions, and a barcode.*

FDA Label Image

Structure (Spironolactone 01)

Chemical structure diagram of the active ingredients Spironolactone and Hydrochlorothiazide. The structure depicts the molecular arrangement and chemical bonds of these compounds used in the tablet dosage form for oral administration.*

FDA Label Image

Figure (Spironolactone 02)

Chemical structure of Spironolactone as the active ingredient in the Spironolactone and Hydrochlorothiazide combination drug. The diagram shows the molecular formula with specific atoms and bonds highlighted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.